About AUTOLUS INC
Autolus is a biotechnology company focused on developing advanced autologous T cell therapies, particularly CAR T cell treatments, for patients with cancer and autoimmune diseases. The company is building a fully integrated, next-generation CAR T platform.
Development of advanced autologous T cell therapiesChimeric Antigen Receptor (CAR) technologyAdvanced cell programming capabilitiesProprietary viral vector and semi-automated cell manufacturing processes
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| AUCATZYL | Department of Veterans Affairs | $401K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AUTOLUS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.